Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery
Norwalk, CT - October 09, 2025 – Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement...
LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly
Norwalk, CT - September 8, 2025 – Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc....
LifeSpan Vision Ventures Invests in Immunis
Norwalk, CT - January 11, 2025 – LifeSpan Vision Ventures, an investment firm specializing in the aging and longevity space, has announced today an investment into Immunis, Inc as part of a $25 million Series A-1 financing round to fund two Phase 2 clinical trials. Immunis is developing multi-active biologics to address age-related diseases. Preclinical data of Immunis’ novel therapy in aged mouse models of muscle disuse atrophy and metabolism were published in GeroScience  a
LifeSpan Vision Ventures Invests in Algen Biotechnologies
Norwalk, CT - November 14 , 2024 – LifeSpan Vision Ventures, an investment firm specializing in the aging and longevity space, today...